A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream
Public ClinicalTrials.gov record NCT06213831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis
Study identification
- NCT ID
- NCT06213831
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Interventions
- Ruxolitinib Cream 1.5% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2024
- Primary completion
- Jul 16, 2025
- Completion
- Jul 16, 2025
- Last update posted
- Aug 12, 2025
2024 – 2025
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Saguaro Dermatology | Phoenix | Arizona | 85008 | — |
| Affiliated Dermatology | Scottsdale | Arizona | 85255 | — |
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| Amicis Research Center Valencia | Northridge | California | 91324 | — |
| Clinical Science Institute Clinical Research Specialists Inc | Santa Monica | California | 90404 | — |
| Advanced Pharma Cr, Llc | Miami | Florida | 33147 | — |
| Sullivan Dermatology North Miami Beach Office | North Miami Beach | Florida | 33162 | — |
| Olympian Clinical Research | Tampa | Florida | 33615 | — |
| St Lukes Clinic Dermatology Ketchum | Ketchum | Idaho | 83340 | — |
| Dawes Fretzin Clinical Research Group Llc | Indianapolis | Indiana | 46250 | — |
| Equity Medical | Bowling Green | Kentucky | 42104 | — |
| Oakland Hills Dermatology Pc | Auburn Hills | Michigan | 48326 | — |
| Revival Research Institute, Llc Troy | Troy | Michigan | 48084 | — |
| Equity Medical, Llc | New York | New York | 10023 | — |
| Red River Research Partners | Fargo | North Dakota | 58103 | — |
| Central Sooner Research | Oklahoma City | Oklahoma | 73170 | — |
| Paddington Testing Co Inc | Philadelphia | Pennsylvania | 19103 | — |
| International Clinical Research Tennessee Llc | Murfreesboro | Tennessee | 37130 | — |
| Dermresearch, Inc. | Austin | Texas | 78759 | — |
| North Texas Center For Clinical Research Ntccr | Frisco | Texas | 75034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06213831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06213831 live on ClinicalTrials.gov.